氟哌噻吨美利曲辛治疗乳腺癌患者焦虑、抑郁情绪的疗效观察

Flupentixol-melitracen therapeutic effect on breast cancer patients' anxiety and depression

目的:评价氟哌噻吨美利曲辛在乳腺癌患者焦虑、抑郁情绪中的治疗效果。方法:利用90项症状清单、焦虑自评量表、抑郁自评量表对筛选的181例存在焦虑、抑郁情绪症状的乳腺癌患者进行评估。随机分为药物治疗组及对照组,治疗组给予氟哌噻吨美利曲辛口服,治疗2周后再次量表评估,评价药效。结果:经药物治疗后存在焦虑情绪的乳腺癌患者中约63.5%症状消失,存在抑郁情绪的乳腺癌患者中约58.6%症状消失。结论:口服氟哌噻吨顿美利曲辛对改善乳腺癌患者焦虑、抑郁情绪问题效果明显。

Objective: To evaluate the flupentixol- melitracen therapeutic effect in the treatment of breast cancer patients' anxiety and depression. Methods: With Hamilton Anxiety,Depression Scale and SCL- 90 to evaluate 181 breast cancer patients with anxiety and depression. Then randomly dividing those patients into treatment group and control group. The treatment group was orally administered with flupentixol- melitracen,and after 2 weeks evaluated all the patients with the same scale. Results: The anxiety symptom of 63. 5% breast cancer patients disappeared after treatment and the depression symptom of 58. 6% breast cancer patients disappeared,too. Conclusion: Flupentixol-melitracen can improve the breast cancer patients' anxiety and depression.